Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

Medchemexpress LLC L-Leucine, N-[4-[(1H-imidazol-5-ylmethyl)amino]-2-(1-naphthalenyl)benzoyl]- | 191102-79-1 | 98.5% | 456.54 | 25 MG
SDP

Supplier:  Medchemexpress LLC 25MGHY12369

Encompass_Preferred

GGTI-2133 is a peptidomimetic and a selective geranylgeranyltransferase I (GGTase-I) inhibitor with an IC50 of 38 nM. It exhibits 140-fold selectivity over farnesyltransferase (FTase) (IC50 of 5.4 μM). GGTI-2133 inhibits the geranylation of Rap-1A with an IC50 of 10 μM. It can be utilized for the study of eosinophilic airway inflammation, such as asthma.

  • Selective geranylgeranyltransferase I (GGTase-I) inhibitor.
  • Shows 140-fold selectivity over farnesyltransferase (FTase).
  • Inhibits the geranylation of Rap-1A.
  • Can be used for the study of eosinophilic airway inflammation such as asthma.
  • Inhibits infiltration of inflammatory cells into airways in mouse experimental asthma (at 5 mg/kg; intraperitoneal injection; once a day; for 10 days).

Catalog No. 50-004-38326


May include imposed supplier surcharges.
Add to Cart

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.